| 29th May 2019 1:06 pm |
RNS |
Result of AGM |
| 28th May 2019 7:00 am |
RNS |
Strategic Investment by Novo Holdings A/S |
| 23rd May 2019 6:04 pm |
RNS |
Director Dealings / Market Share Purchase |
| 2nd May 2019 2:53 pm |
RNS |
Long Term Incentive Plan Option Grant |
| 1st May 2019 12:52 pm |
RNS |
REPLACEMENT: Total Voting Rights |
| 1st May 2019 11:33 am |
RNS |
Total Voting Rights |
| 30th Apr 2019 5:38 pm |
RNS |
Holdings in Company |
| 30th Apr 2019 1:35 pm |
RNS |
Oxford Biomedica to present at the ASGCT |
| 30th Apr 2019 1:15 pm |
RNS |
Axovant doses second cohort of AXO-Lenti-PD |
| 25th Apr 2019 3:38 pm |
RNS |
Director Dealings / Market Share Purchase |
| 23rd Apr 2019 1:47 pm |
RNS |
Deferred Bonus Plan and LTIP Option Grants |
| 23rd Apr 2019 11:38 am |
RNS |
Director Dealings / Market Share Transactions |
| 18th Apr 2019 5:33 pm |
RNS |
Exercise of warrants |
| 18th Apr 2019 7:00 am |
RNS |
Annual Report and Accounts & AGM Notification |
| 1st Apr 2019 11:40 am |
RNS |
Total Voting Rights |
| 26th Mar 2019 12:57 pm |
RNS |
Director Dealings / Market Share Purchase |
| 26th Mar 2019 8:25 am |
RNS |
Japanese approval of Kymriah® (tisagenlecleucel) |
| 14th Mar 2019 7:00 am |
RNS |
Preliminary Results |
| 12th Mar 2019 7:00 am |
RNS |
OXB announces R&D collaboration with Microsoft |
| 11th Mar 2019 10:38 am |
RNS |
Axovant's update on Phase 2 trial of AXO-Lenti-PD |
| 1st Mar 2019 9:30 am |
RNS |
Total Voting Rights |
| 25th Feb 2019 12:23 pm |
RNS |
Director Dealings / Market Share Purchase |
| 8th Feb 2019 7:00 am |
RNS |
Notice of Results |
| 7th Feb 2019 11:49 am |
RNS |
Director/PDMR Shareholding |
| 7th Feb 2019 9:22 am |
RNS |
Update on programmes outlicensed to Sanofi |
| 6th Feb 2019 11:00 am |
RNS |
Director Dealings / Market Share Transactions |
| 5th Feb 2019 10:22 am |
RNS |
Director Dealings / Market Share Purchase |
| 1st Feb 2019 10:00 am |
RNS |
Total Voting Rights |
| 24th Jan 2019 11:20 am |
RNS |
Director Dealings / Market Share Purchase |
| 3rd Jan 2019 12:20 pm |
RNS |
Block listing Interim Review |
| 2nd Jan 2019 10:17 am |
RNS |
Total Voting Rights |
| 21st Dec 2018 1:16 pm |
RNS |
Director Dealings / Market Share Purchase |
| 6th Dec 2018 4:11 pm |
RNS |
Axovant FDA meeting feedback |
| 3rd Dec 2018 9:53 am |
RNS |
Total Voting Rights |
| 3rd Dec 2018 7:00 am |
RNS |
Longer term Kymriah efficacy and safety data |
| 23rd Nov 2018 10:41 am |
RNS |
Director Dealings |
| 23rd Nov 2018 7:00 am |
RNS |
Oxford Biomedica form digital framework initiative |
| 9th Nov 2018 7:00 am |
RNS |
Block listing application |
| 1st Nov 2018 2:41 pm |
RNS |
Total Voting Rights |
| 25th Oct 2018 7:00 am |
RNS |
Axovant Doses First Patient with AXO-Lenti-PD |
